Botulinum toxin related research in maxillofacial plastic and reconstructive surgery by Tae-Geon Kwon
EDITORIAL Open Access
Botulinum toxin related research in
maxillofacial plastic and reconstructive
surgery
Tae-Geon Kwon
Botulism caused by food poisoning was characterized by
mydriasis and skeletal muscle paralysis, which was first
described by Justinus Kerner in 1820 [1]. The cause of
botulism was botulinum neurotoxin produced by anaer-
obic, spore-forming bacteria of the genus Clostridium
[2]. Botulinum toxin (BTX) became to be the first med-
ically applied toxin. The first clinical use of BTX was re-
ported concerning the treatment of strabismus in
ophthalmologic field in 1980 [3]. Nine years later, the
Food and Drug Administration (FDA) approved the clin-
ical application of BTX for adult strabismus and bleph-
arospasm [4]. BTX inhibits acetylcholine exocytosis at
neuromuscular junction of the preganglionic sympa-
thetic/parasympathetic nerve fibers and postganglionic
parasympathetic nerves [5].
BTX is clinically administrated to treat various thera-
peutic indications: strabismus, migraine, bladder dys-
tonia, hyperhidrosis, cervical dystonia, upper limb
spasticity, voice abnormality, chronic pain management,
and cerebral palsy [6]. Recently, the most popular indi-
cation in public is the control of facial wrinkle [7]. In
oral and maxillofacial surgery field, BTX injection is ap-
plied not only for cosmetic purposes such as glabella line
correction, platysma band correction, or gummy smile
but also for therapeutic indications such as masseteric
or temporalis muscle hypertrophy [8–10], temporoman-
dibular joint disorders [9, 11], salivary gland secretory
disorders (including sialorrhea, Frey syndrome) [12],
hypertrophic scars [13], facial pains [14], and facial par-
alysis [15, 16]. Especially in dental field, it had been re-
ported that BTX improved painful symptoms as high as
90 % of temporomandibular joint disorders related to
masticatory muscles [17]. In cosmetic purpose in dental
field, excessive gingival exposure during smile or
asymmetric smile can be corrected by the BTX injection
into peri-oral muscles [18, 19]. Therefore, even though
BTX treatment had been historically dermatologists and
neurologists’ jurisdiction, it now became the dentists’
jurisdiction because the training and scientific know-
ledge covers the entire head and neck region [19].
However, there are a number of complications associ-
ated with the BTX injection especially related with the
accidental overdose. According to the previous report,
there are various local and systemic side effects after
BTX injection. Pain, edema, headache, and bruising
would be the common loco-regional side effects, and
nausea, fatigue, headache, facial pain, flu-like symptoms,
anxiety, and itching can appear as systemic side effects
after BTX administration [1, 20]. In 2005, it was re-
ported that the adverse event reported to the FDA (Dec
1989~May 2003) after therapeutic and cosmetic use of
BTX was 1437 cases. Among these, 217 serious adverse
events were reported including 28 reported deaths; re-
spiratory arrest (n = 6), myocardial infarction (n = 5),
cerebrovascular accident (n = 3), pulmonary embolism
(n = 2), and others (n = 3) [21]. All of them were related
to therapeutic application rather than cosmetic purpose
of the BTX.
Even though there are numerous publications report-
ing successful outcomes after BTX application, there are
only a few scientific reports with high level of scientific
evidence. Because the clinical research had not been car-
ried out with randomized, controlled, blinded settings,
more clinical and experimental research should be en-
couraged. Clinical research need to be carried out more
tightly under controlled condition with a prospective,
randomized design rather than demonstration of suc-
cessful case series. At the same time, to overcome funda-
mental limitations of the BTX, the basic research is
needed to advance and improve the clinical application
of BTX.
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